As of August 28, 2026, Alterity Therapeutics Limited (ATHE) has a DilutionWatch DilutionScore of 46/100, rated MEDIUM dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Alterity Therapeutics Limited has a market capitalization of $77.91M, 9.13B shares outstanding.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Score Breakdown
📊Float Risk—
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for ATHE.
Market Data
Market Cap$77.91M
Shares Outstanding9.13B
FloatN/A
Cash$35.36M
Debt$70.7K
Short InterestN/A
Institutional Holdings
1.9% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
Short Interest
Short Interest21.1K
Days to Cover2.0
% of FloatN/A
FINRA data as of Jul 31, 2026
Recent SEC Activity
No recent SEC insights
Recent News
No recent news
Track ATHE Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ATHE — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
Score Coverage Note
- Float Risk is excluded because public-float data is unavailable.